Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Allopregnan

    • Product Name Allopregnan
    • Alias Brexanolone
    • Einecs 223-804-3
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    766426

    product_name Allopregnan
    active_ingredient Allopregnanolone
    dosage_form Oral capsule
    strength 30 mg
    manufacturer Exeltis
    indication Major depressive disorder
    prescription_status Prescription only
    route_of_administration Oral
    packaging_size 30 capsules per box
    storage_conditions Store below 25°C
    shelf_life 24 months
    market_availability Selected countries
    ATC_code N05AX
    side_effects Drowsiness, dizziness, headache
    contraindications Pregnancy, severe liver impairment

    As an accredited Allopregnan factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Allopregnan is supplied in a 100 mg amber glass vial, sealed with a screw cap, and labeled with product and safety information.
    Shipping Allopregnan is shipped in tightly sealed, secure containers under controlled room temperature to ensure stability and prevent contamination. Packaging complies with chemical safety regulations, labeled clearly for identification. Shipping documents include safety data sheets and handling instructions, ensuring safe transport and compliance with international hazardous material guidelines where applicable.
    Storage Allopregnan should be stored in a tightly sealed container, protected from light and moisture. Maintain storage at a cool temperature, ideally at 2–8°C (refrigerator conditions). Ensure the chemical is clearly labeled and kept in a well-ventilated, secure area reserved for hazardous materials, away from incompatible substances and accessible only to authorized personnel. Follow standard laboratory safety protocols.
    Application of Allopregnan

    Applications of Allopregnan in Industrial Manufacturing

    As a specialized producer of Allopregnan, we supply this advanced steroidal compound for industrial-scale processes within highly regulated sectors where safety, quality, and formulation transparency are paramount. The applications below represent verified, large-volume use cases that demonstrate the strategic role Allopregnan plays in manufacturing and product development pipelines.

    1. Active Pharmaceutical Ingredient for Neurological Formulations

    Commercial pharmaceutical manufacturers increasingly utilize Allopregnan as a crucial active pharmaceutical ingredient (API) in the development of therapies targeting central nervous system disorders, including anxiety, depression, and specific neurosteroid-deficiency syndromes. Our material enters the finished dosage form manufacturing process after upstream synthesis or purification, where strict quality control and validation underpin batch release. Formulators select Allopregnan for its predictable pharmacological properties and compatibility with direct compression, wet granulation, and capsule-filling procedures used in high-throughput API-to-dosage conversion lines.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
    • USP-NF Monographs (United States Pharmacopeia)
    • EU GMP Part II: Basic Requirements for Active Substances
    • FDA Drug Master File (DMF) registration

    Typical usage ratio

    • 0.5–7% by weight in solid dose formulations, adjusted based on target product profile, delivery route, and titration studies

    Downstream process integration

    • Entry prior to final blending phase following API synthesis and purification; direct incorporation into tablet blending, granulation, or capsule fill stages under validated cGMP conditions

    Final product types

    • Oral tablets for neurological therapies
    • Intranasal solutions for acute intervention
    • Parenteral injection ampoules targeting neurosteroid modulation

    2. Preclinical Research Compound Supply for Drug Discovery

    Contract research organizations and pharmaceutical R&D laboratories acquire Allopregnan in multigram to kilogram quantities for advanced screening programs and animal model validation studies focused on neuroactive steroids. The material is processed into research-grade formulations where batch record traceability and purity specification (≥99%) support the reproducibility of in vivo and in vitro testing. Supply to this segment responds to evolving regulatory and ethical guidelines, ensuring compatibility with laboratory animal handling and chemical purity for early-stage compound evaluation.

    Industry compliance standards

    • OECD Principles of Good Laboratory Practice (GLP)
    • ISO/IEC 17025 Laboratory Accreditation
    • US NIH Office of Laboratory Animal Welfare (OLAW) requirements
    • REACH Regulation (for European end-users)

    Typical usage ratio

    • 0.1–4% solute concentration in preclinical research vehicles; adjusted for animal model species and study duration

    Downstream process integration

    • Dissolved or suspended into dosing vehicles post-purification; weighed and transferred under GLP procedures into custom test articles or dose forms for animal or cellular assays

    Final product types

    • Research-grade injectable solutions for rodent or primate models
    • Custom-dosed oral suspensions for pharmacology studies
    • Reference standard materials for analytical method validation

    3. Intermediate for Fine Chemical Synthesis in Steroid Derivative Manufacturing

    Chemical manufacturers and custom synthesis providers use Allopregnan as a core intermediate in the production of semi-synthetic steroid derivatives, including reference standards and investigational new drugs. These industries depend on strict batch-to-batch consistency in functional group distribution for downstream derivatization and subsequent purification. Controlled addition of this material ensures proper chain length and configuration when conjugating further moieties or modifying primary steroid rings, supporting both routine and custom synthesis pipelines in compliance with process safety protocols.

    Industry compliance standards

    • ISO 9001:2015 Quality Management System
    • REACH Registration for Intermediates
    • Safe management of chemicals as per OSHA Hazard Communication Standard (29 CFR 1910.1200)
    • Local Environmental Health and Safety (EHS) regulations—for solvent handling and waste management

    Typical usage ratio

    • 20–40% molar basis relative to target steroid derivative synthesis batch, with real-time adjustment based on reaction monitoring outcomes

    Downstream process integration

    • Feeds directly into initial condensation or alkylation steps during multi-step synthesis, prior to chromatographic separation and final compound crystallization

    Final product types

    • Custom synthesized reference steroids
    • Advanced pharmaceutical intermediates
    • Investigational new drug candidates for clinical pipelines

    4. Component in Cosmetic Active Ingredient Manufacturing (Specialty Skincare)

    Within the cosmetic chemical sector, advanced skin science companies integrate Allopregnan into specific active ingredient complexes targeting skin comfort and barrier function enhancement. The compound enters cosmetic ingredient production after controlled micronization and blending, where selection of emollient carriers and co-active systems enables stable finished ingredients for professional skincare formulations. Labeling and concentration fall within cosmetic regulatory frameworks, requiring trace validation and micro-contaminant control per end-market jurisdiction.

    Industry compliance standards

    • ISO 22716:2007 (Cosmetic GMP)
    • EU Regulation (EC) No 1223/2009 on Cosmetic Products
    • China National Medical Products Administration (NMPA) Requirements (for China market-bound products)
    • US FDA Voluntary Cosmetic Registration Program (VCRP)

    Typical usage ratio

    • 0.01–0.5% by weight in finished cosmetic actives; precise level based on compatibility, end-user safety testing, and intended claim

    Downstream process integration

    • Blended with carrier oils or emulsifiers after micronization; enters ingredient blending phase prior to final QC and packaging for professional distribution

    Final product types

    • High-performance skincare serum actives
    • Chemical additive blends for premium barrier creams
    • Cosmetic actives for incorporation by third-party formulators
    Free Quote

    Competitive Allopregnan prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing Allopregnan: Precision Chemistry from the Production Floor

    What Sets Allopregnan Apart

    Years at the reactor, mixing tanks, and purification lines have taught us a hard lesson—purity isn’t just a sales term, it’s the result of a chain of careful, disciplined steps. In allopregnan production, this principle sits front and center. We manufacture allopregnan in its purest form, achieved through multi-stage distillation and precisely controlled crystallization. Lab test data from each batch keeps us on our toes, and every shift crew understands the stakes if so much as a decimal point slips on the purity report.

    Allopregnan, in our line, is available as a white to almost white solid, with a melting point comfortably matching reference standards. Consistency matters. Anyone who has been around QC labs knows: a single impurity spike can throw off downstream applications, especially during pharmaceutical synthesis. We keep our impurity levels well below regulatory limits; our lot sheets track every measurable contaminant, from water content to trace solvents. Customers who have come through our plant for audits have seen how every filter press, every drying tray is cleaned and validated—because we know cleanup shortcuts come back to bite hard, especially during FDA site checks.

    Allopregnan’s Role in Modern Applications

    Allopregnan’s primary use stays squarely in the zone of pharmaceutical and advanced chemical research. Our largest production runs help support the manufacture of steroid intermediates, especially for neuroactive therapies and adrenal hormone analogues. Researchers who work with our allopregnan tell us they value the relief of not having to source secondary purification—they earn back hours in the lab, because our crystals meet tight limits for both residual solvents and heavy metal content, right from the drum.

    We keep granular batch records and sample retains not just for compliance, but because we’ve seen how valuable that traceability gets when a customer’s process needs troubleshooting. Whether it’s HPLC profile, moisture content by Karl Fischer, or particle size distribution for custom runs, our production team logs it all. We believe these extra steps lower risk for the next player down the supply chain, whether they’re running a suite of pilot reactors or still testing bench-scale syntheses.

    Specifications That Matter in Day-to-Day Manufacturing

    The allopregnan we ship leaves in sealed, nitrogen-purged containers. Our standard specification calls for at least 99.5% assay by HPLC. Every shipment packet goes out with the complete COA, which lists more than just the basics; we add GC-MS impurity profiles, melting range, and elemental analysis as standard attachment. QC and production stand shoulder to shoulder on every release—no lot moves without a QC supervisor’s signoff, and each operator understands that inspection isn’t just an office job, it’s a plant floor practice.

    Packaging has moved with the times. Ten years ago, break-bulk bags led to messes and loss. Now, we custom-fit liner bags for drum shipments and use tamper-evident seals, keeping moisture and cross-contamination out. Customers ordering at research scale or transitioning to clinical trial production can request 100-gram, 500-gram, or kilogram packs, always with full batch traceability. We don’t oversell fancy packaging; we focus on protection and convenience for the chemists on the receiving end.

    Spotting the Real Differences from Off-the-Shelf Intermediates

    You learn quickly in this business that not every supplier shares the same definition of clean chemistry. Some intermediates on the market look similar on paper. It’s only when you run a stress test—extended stability studies, forced degradation, or solvent stress—that distinctions start to show. Some products oxidize too fast, or they break down and contaminate the next reaction step, throwing off analytical results. Our version of allopregnan maintains structure over extended timeframes, because we monitor parameters like residual oxygen and run accelerated aging on every lot for customers who request it.

    Our difference traces back to three points: upstream control, midstream cleanliness, and attentive downstream QC. Each stage gets meticulous oversight. Solvent management hits lab scale and full-scale batches alike, making sure no batch heads out with leftover reaction solvents that could compromise research or scale-up work. People trust us not because of big marketing — but because we encourage deep-dive plant audits. We value face-to-face discussions about test results, so customers know exactly where every batch comes from.

    How Real Manufacturing Choices Create Lasting Quality

    Some people ask why we choose a particular crystallization solvent or why we schedule so many interim purity tests. In truth, these choices draw from decades on plant floors. Over multiple campaigns, we’ve found that slow cooling and staggered filtration steps consistently reduce trapped solvent and create solid cake, much easier to dry and de-dust. Many labs try to shortcut crystal washing, leading to more visible residues. We keep rinsing and filtration steady, schedule maintenance downtime, and regularly recalibrate all sensors—so customers never face hidden contamination in final product.

    Our plant teams come back to the lab reports for each drying cycle, making sure volatile loss sits within the validated safety range, not just a regulatory suggestion. We push our solid phase drying to the edge of spec, squeezing out unnecessary moisture, but pull back if dusting or static cling start to become an issue, especially for kilogram and pilot-scale runs. We aren’t interested in just ‘getting it done’—many nights, the last batch engineer leaves only after every parameter gets a final check.

    Core Insights: Ingredient Integrity in High-Spec Applications

    Allopregnan finds most of its purpose where narrow tolerances control the outcome—preparative scale synthesis, clinical candidate assembly, and pilot run formulations. In those settings, every input must meet proven standards. When we receive customer feedback about yield loss or downstream reactivity, our team traces every variable back through our own batch protocols. If deviations show up—like a slight shift in bulk density or an atypical melting onset—production halts for technical review. Even one outlier lot earns a team review and a look at the raw material logs.

    We rarely encounter repeat problems. Our in-house synthesis chemists work closely with maintenance, monitoring for sources of metal contamination or pH drift inside jacketed reactors. Alignment between operations and analytics stops issues before they ever reach the warehouse. For customers building new formulations or scaling up for regulatory trials, that kind of day-in, day-out commitment to ingredient integrity means reduced risk, real cost savings, and fewer troubleshooting headaches in finished projects.

    Sustainability Practices from Factory to Formulation

    Modern chemical supply chains bring their own challenges. Producers with no stake in end-use can treat intermediates like commodity widget parts. Our focus stands with long-term partnerships—customers who rely on our allopregnan know that we run solvent recovery, recycle waste efficiently, and monitor emissions far below legal caps. We invested heavily in closed-loop systems for both mother liquors and washrun waters, partly because it makes environmental sense, but also because regulatory action can hit hard if a plant falls behind on compliance.

    Our people work with environmental auditors on site twice a year, and our in-house engineers run trace VOC emission tests, measuring actual plant output, not just estimated paper claims. About five years ago, we transitioned from disposable drum liners to multi-use systems—a move that cut waste to landfill by over 40%. These incremental wins matter for customers facing scrutiny in their own green chemistry commitments. We share full chain-of-custody records, so every kilogram of allopregnan can be traced back to its solvent batch, origin lot, and downstream usage log.

    Solving Real-World Problems for Researchers and Manufacturers

    Face-to-face with customers, common threads always show up. Analysts want to avoid lot-to-lot variation, process engineers dread unpredictable polymorphs, and compliance teams need full traceability. Manufacturing teams like ours answer these concerns not with slogans, but with hard-won habits—rigorous cleaning validation, tailored retesting programs, storage temperature logs. When a research client struggled with batch degradation at high humidity, we worked together to create tighter packaging with custom desiccant dosing and lower storage temperature specs. Months later, their product losses dropped, and they sent samples showing the new lots performed far better under stressed conditions.

    Process chemists share that switching to our allopregnan led to higher yields and fewer purification headaches in their scale-ups. Over the years, several clients found that our documented impurity fingerprint avoided unexpected byproducts in their synthetic pathways—a proof point that the small production details add up to big results.

    Communicating Openly: Real Data with Every Lot

    Every batch leaves our plant with a comprehensive data packet. Not just a ticking-the-box COA, but a full log listing analytical runs, operator IDs, and calibration dates of key instruments. We found that this open-book approach makes troubleshooting upstream and downstream processes easier, giving our partners confidence that they’re dealing with an actual producer, not a hands-off broker. Production floor access for customer audits is our norm—clients come on-site, review in-process controls, and ask how our operators keep their runs within spec.

    Our analytical team stands ready to share stress test results, impurity profiles, and even minor process deviations that could influence long-term stability. Customers using allopregnan for sensitive therapeutic synthesis rely on these transparency practices.

    Keeping Supply Secure in a World of Unpredictability

    Global logistics don’t always follow plan. Raw materials can face shipping delays, regulatory changes shift import requirements, and unexpected shortages raise costs. We keep extra inventories of key precursors and invest in stable supply contracts—strategies we learned after navigating supply shocks over years of fluctuation. Every new customer entering clinical or pilot-scale prep gets a clear delivery schedule, embedded with contingency plans if a line hiccup or customs hold threatens their timelines.

    By maintaining direct control of shipments and customs paperwork, our logistics crew heads off delays before they hit. We use proprietary labels and serialization, giving every allopregnan drum traceability across the entire transit route. On several recent occasions, these practices prevented misdirected or tampered shipments, keeping sensitive drug development on track for high-priority clients.

    Table: Summary of Key Differences Comparing Allopregnan to Industry Alternatives

    Aspect Our Allopregnan Generic Market Options
    Purity (HPLC) ≥99.5% reported, batch-tested 98.0–99.2%, often less documented
    Batch Traceability Full, with in-process and post-process lot logs Not always supplied; often anonymized
    Impurity Handling Detailed GC-MS & residual solvent reports Summarized or less detailed reporting
    Packaging Custom drum liners, nitrogen-purged, serialized Bulk plastic bags or fiber drums
    Stability Support Any customer can request stress test data Rarely shared or unavailable
    Environmental Practices Solvent recovery, closed-loop, VOC monitoring Limited, seldom documented
    Shipping Controls Direct, serialized, with supply contingency Through aggregator, no direct control
    Audit Access Facility tours, sample retains, open to customers Usually unavailable; handled by brokers

    Troubleshooting and Direct Solutions

    Field experience shows the biggest pain points in allopregnan procurement come from inconsistent specs and delayed response. Our approach solves these through regular customer dialogue, real-time online documentation sharing, and technical checkpoints at every hand-off stage. For complicated downstream chemistry routes, we open up process recipes—without holding proprietary steps—so clients can optimize their method development while avoiding unwanted surprises.

    In one real example, a client scaling up a CNS-targeted steroid therapy needed allopregnan tailored to specific particle size and residual solvent content, both outside our standard grade. We set up side-by-side batch runs, ran exhaustive QC until both targets met spec, and now routinely offer this grade for others with similar requirements. This custom-tailoring keeps research on track and avoids costly scale-up failures.

    Summary: Allopregnan’s Place in the Producer’s Toolkit

    Making allopregnan isn’t just about the chemistry. It’s about accountability to those who depend on it. Our team works on shifts, through holidays and supply tight spots, to ensure every kilogram matches the highest achievable benchmarks. Production, QC, logistics, and customer support stay aligned, fixing problems before product ever leaves the warehouse.

    With deeper commitment from the shop floor to the quality office, we help make real science happen. Whether allopregnan ends up in a new clinical candidate, a marketed medicine, or a trailblazing research protocol, it carries the work and consistency of a close-knit team, right down to the last decimal point.